美國(guó)創(chuàng)新研究公司（Innovative Research of America，IRA）是專(zhuān)業(yè)的動(dòng)物皮下嵌入式給藥專(zhuān)業(yè)供應(yīng)商。公司的Matrix-Driven Delivery系統(tǒng)使藥物的等量的釋放得到了保證，釋放時(shí)間可以長(zhǎng)達(dá)90天，這樣不僅減輕了您的負(fù)擔(dān)也減少了對(duì)動(dòng)物的傷害。豐富的產(chǎn)品線大約600種，可以按客戶(hù)要求定制您實(shí)驗(yàn)需要的藥劑。Innovative Research of America豐富的文獻(xiàn)引用，使穩(wěn)定給藥成為可能；減少對(duì)動(dòng)物的傷害。
The Research Solution: Changing The Time Course Of Drug Delivery
The good news is that times have changed. Our proven Drug Delivery Technology is helping investigators eliminate the need for unreliable, intermittent injections. Since 1980, Innovative Research of America has been the leader in supplying scientists with long term continuous release pellets embedded with active products. Our technology provides finished products, in a ready-to-implant form, utilizing our Matrix-Driven Delivery (MDD) Pellet System. The pellets are intended for, although not limited to, simple subcutaneous implantation in laboratory animals.
The unique engineering of the (MDD) Pellet System integrates the three principles of diffusion, erosion and concentration gradients. It generates a finished pellet with a biodegradable matrix that effectively and continuously releases the active product in the animal.
The pellet delivery system can help the investigator take charge of standardizing and reproducing research results. It helps overcome problems commonly encountered by researchers who employ conventional delivery methods.
Scientists from several research disciplines have documented in scientific literature that our Pellet Delivery System is effective, consistent, reproducible, economical, reliable, and safe for the animal.
在線咨詢(xún)